Cargando…
Identification of selective inhibitors of Helicobacter pylori IMPDH as a targeted therapy for the infection
Helicobacter pylori (H. pylori), the major cause of several gastric disorders has been recognied as a type I carcinogen. By virtue of resistance developed by H. pylori strains, currently used antibiotic based treatments rather demonstrate high failure rates. Hence, there is an emerging need for iden...
Autores principales: | Juvale, Kapil, Purushothaman, Gayathri, Singh, Vijay, Shaik, Althaf, Ravi, Srimadhavi, Thiruvenkatam, Vijay, Kirubakaran, Sivapriya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336804/ https://www.ncbi.nlm.nih.gov/pubmed/30655593 http://dx.doi.org/10.1038/s41598-018-37490-x |
Ejemplares similares
-
Crystal structure and Hirshfeld surface analysis of ethyl 5-phenylisoxazole-3-carboxylate
por: Shaik, Althaf, et al.
Publicado: (2017) -
High yield bacterial expression, purification and characterisation of bioactive Human Tousled-like Kinase 1B involved in cancer
por: Bhoir, Siddhant, et al.
Publicado: (2018) -
Design, Synthesis, and Docking Studies of New Torin2 Analogs as Potential ATR/mTOR Kinase Inhibitors †
por: Shaik, Althaf, et al.
Publicado: (2018) -
Recombinant Tumor Suppressor TSC1 Differentially Interacts
with Escherichia coli DnaK and Human
HSP70
por: Natarajan, Nalini, et al.
Publicado: (2020) -
Irigenin, a novel lead from Iris confusa for management of Helicobacter pylori infection with selective COX-2 and HpIMPDH inhibitory potential
por: Abdel-Baki, Passent M., et al.
Publicado: (2022)